BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 30504326)

  • 1. The rheumatology/hematology interface: CAPS and MAS diagnosis and management.
    Gansner JM; Berliner N
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):313-317. PubMed ID: 30504326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management.
    Henderson LA; Cron RQ
    Paediatr Drugs; 2020 Feb; 22(1):29-44. PubMed ID: 31732958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature.
    Heijstek V; Habib M; van der Palen R; van Doorn R; Muller PH
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):13. PubMed ID: 33568193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists.
    Carter-Febres M; Lozano-Chinga M; Thomsen W; Treemarcki EB; James KE; Fluchel M
    J Pediatr; 2023 Apr; 255():65-71.e6. PubMed ID: 36328191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calm in the midst of cytokine storm: a collaborative approach to the diagnosis and treatment of hemophagocytic lymphohistiocytosis and macrophage activation syndrome.
    Halyabar O; Chang MH; Schoettler ML; Schwartz MA; Baris EH; Benson LA; Biggs CM; Gorman M; Lehmann L; Lo MS; Nigrovic PA; Platt CD; Priebe GP; Rowe J; Sundel RP; Surana NK; Weinacht KG; Mann A; Yuen JC; Meleedy-Rey P; Starmer A; Banerjee T; Dedeoglu F; Degar BA; Hazen MM; Henderson LA
    Pediatr Rheumatol Online J; 2019 Feb; 17(1):7. PubMed ID: 30764840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
    Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.
    Krei JM; Møller HJ; Larsen JB
    Clin Exp Immunol; 2021 Feb; 203(2):174-182. PubMed ID: 33128796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rheumatologic emergencies.
    Gutiérrez-González LA
    Clin Rheumatol; 2015 Dec; 34(12):2011-9. PubMed ID: 26099604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Catastrophic antiphospholipid syndrome].
    Costedoat-Chalumeau N; Arnaud L; Saadoun D; Chastre J; Leroux G; Cacoub P; Amoura Z; Piette JC
    Rev Med Interne; 2012 Apr; 33(4):194-9. PubMed ID: 22341856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult macrophage activation syndrome-haemophagocytic lymphohistiocytosis: 'of plasma exchange and immunosuppressive escalation strategies' - a single centre reflection.
    Lorenz G; Schul L; Schraml F; Riedhammer KM; Einwächter H; Verbeek M; Slotta-Huspenina J; Schmaderer C; Küchle C; Heemann U; Moog P
    Lupus; 2020 Mar; 29(3):324-333. PubMed ID: 32013725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW;
    Ann Rheum Dis; 2023 Oct; 82(10):1271-1285. PubMed ID: 37487610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of macrophage activation syndrome and treatment progression.
    Dong Y; Wang T; Wu H
    Front Immunol; 2024; 15():1389710. PubMed ID: 38736876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
    Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
    J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS).
    Shakoory B; Geerlinks A; Wilejto M; Kernan K; Hines M; Romano M; Piskin D; Ravelli A; Sinha R; Aletaha D; Allen C; Bassiri H; Behrens EM; Carcillo J; Carl L; Chatham W; Cohen JI; Cron RQ; Drewniak E; Grom AA; Henderson LA; Horne A; Jordan MB; Nichols KE; Schulert G; Vastert S; Demirkaya E; Goldbach-Mansky R; de Benedetti F; Marsh RA; Canna SW
    Arthritis Rheumatol; 2023 Oct; 75(10):1714-1732. PubMed ID: 37486733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catastrophic antiphospholipid antibody syndrome in systemic lupus erythematosus: an autopsy case report of a young woman.
    Mizuno R; Fujimoto S; Fujimoto T; Nishino T; Shiiki H; Hashimoto T; Nakamura S; Dohi K
    Intern Med; 2000 Oct; 39(10):856-9. PubMed ID: 11030215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and Management of Secondary HLH/MAS Following HSCT and CAR-T Cell Therapy in Adults; A Review of the Literature and a Survey of Practice Within EBMT Centres on Behalf of the Autoimmune Diseases Working Party (ADWP) and Transplant Complications Working Party (TCWP).
    Sandler RD; Tattersall RS; Schoemans H; Greco R; Badoglio M; Labopin M; Alexander T; Kirgizov K; Rovira M; Saif M; Saccardi R; Delgado J; Peric Z; Koenecke C; Penack O; Basak G; Snowden JA
    Front Immunol; 2020; 11():524. PubMed ID: 32296434
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemophagocytic Lymphohistiocytosis Gene Variants in Childhood-Onset Systemic Lupus Erythematosus With Macrophage Activation Syndrome.
    Lahiry P; Naumenko S; Couse M; Liao F; Dominguez D; Knight A; Levy DM; Misztal M; Ng LWK; Hiraki LT
    J Rheumatol; 2022 Oct; 49(10):1146-1151. PubMed ID: 35649546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation syndrome in pediatrics.
    Alongi A; Naddei R; De Miglio L; Natoli V; Ravelli A
    Pediatr Allergy Immunol; 2020 Feb; 31 Suppl 24():13-15. PubMed ID: 32017214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Personalized Diagnostic and Treatment Approach for Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Kumar B; Aleem S; Saleh H; Petts J; Ballas ZK
    J Clin Immunol; 2017 Oct; 37(7):638-643. PubMed ID: 28871523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.